Applied Biosystems (ABI) Tops Q4 EPS View by 4c
More News related to ABI
- Applied Biosystems Teams With Leaders in Connecticut and New Jersey to Drive Stem Cell Research
- Applied Biosystems to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference on September 9
- Applied Biosystems Announces Internet Availability of Its 2008 Annual Report on Form 10-K
- Applied Biosystems Expands Sequencing-based RNA Analysis Solutions Portfolio
- Applied Biosystems Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger With Invitrogen Corporation
More News related to Earnings
- BioForm Medical (BFRM) Reports Q4 Loss of $0.43; Guides FY09 Sales
- Alloy (ALOY) Reports Q2 Loss of $0.10
- iMergent (IIG) Reports Q4 EPS of $0.05
- Martek Biosciences (MATK) Tops Q3 View By 4c; Martek Issues Upside FY08 Upside Guidance
- Pike Electric (PEC) Tops Q4 View; Guides FY09
Applied Biosystems (NYSE: ABI) reports Q4 EPS of $0.49, 4 cents better than the analyst estimate of $0.45. Revenues for the quarter were $609 million, versus the consensus of $589.74 million.
Applera Corporation-Applied Biosystems Group develops and markets instrument-based systems, consumables, software, and services.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
